SORL1
protein-codingsortilin related receptor 1, the group of Fibronectin type III domain containing
Gene summary
This gene encodes a mosaic protein that belongs to at least two families: the vacuolar protein sorting 10 (VPS10) domain-containing receptor family, and the low density lipoprotein receptor (LDLR) family. The encoded protein also contains fibronectin type III repeats and an epidermal growth factor repeat. The encoded preproprotein is proteolytically processed to generate the mature receptor, which likely plays roles in endocytosis and sorting. Mutations in this gene may be associated with Alzheimer's disease. [provided by RefSeq, Feb 2016]
- C11orf32
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~181.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015140
Submitter: Orphanet
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SORL1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003105.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 10 | 144 | 28 | 183 | |
| missense | 1 | 547 | 50 | 12 | 610 | |
| nonsense | 10 | 1 | 11 | |||
| start loss | 0 | |||||
| frameshift | 8 | 2 | 1 | 11 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 18 | 25 | ||
| Total | 19 | 10 | 577 | 194 | 40 | 840 |
Highest pathogenic variant AF is 0.000010261448
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003096.2 | 48 | MANE Select | |
| Ensembl | ENSP00000260197.6 | 48 | MANE Select | |
| Ensembl | ENSP00000434634.1 | 27 | Standard | |
| Ensembl | ENSP00000434634.1 | 27 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of proteins
- Amyloid fiber formation
Biological Process
- protein targeting
- protein targeting to lysosome
- lipid transport
- post-Golgi vesicle-mediated transport
- receptor-mediated endocytosis
Molecular Function
- amyloid-beta binding
- transmembrane signaling receptor activity
- low-density lipoprotein particle receptor activity
- protein binding
- low-density lipoprotein particle binding
Cellular Component
- Golgi membrane
- extracellular space
- nuclear envelope lumen
- endosome
- early endosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000260197
- Coding exons
- 48
- Length
- 181491
- Individuals with no LoFs
- 125655
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 93
- Defined
- 125748
- p
- 0.000370
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.03 | 1068 | 1.27e+3 | 0.840 | 0.0000738 | 14657 |
| Missense (PolyPhen) | 388 | 533.62 | 0.72711 | 6113 | ||
| Synonymous | 0.855 | 478 | 502 | 0.951 | 0.0000320 | 4109 |
| Loss of Function | 6.85 | 42 | 124 | 0.337 | 0.00000672 | 1379 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00033 | 0.00032 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.00048 | 0.00047 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00065 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Likely to be a multifunctional endocytic receptor, that may be implicated in the uptake of lipoproteins and of proteases. Binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. Binds the receptor- associated protein (RAP). Could play a role in cell-cell interaction. Involved in APP trafficking to and from the Golgi apparatus. It probably acts as a sorting receptor that protects APP from trafficking to late endosome and from processing into amyloid beta, thereby reducing the burden of amyloidogenic peptide formation. Involved in the regulation of smooth muscle cells migration, probably through PLAUR binding and decreased internalization. {ECO:0000269|PubMed:14764453, ECO:0000269|PubMed:16174740}.;
- Disease
- DISEASE: Alzheimer disease (AD) [MIM:104300]: Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C- terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death. {ECO:0000269|PubMed:21220680, ECO:0000269|PubMed:22472873, ECO:0000269|PubMed:23565137}. Note=The gene represented in this entry is involved in disease pathogenesis.;
Intolerance Scores
- LoFtool
- 0.0875
- RVIS EVS
- -2.34
- RVIS percentile EVS
- 1.16
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.882
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |